Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 20628400)

1.

Regulation of ABC transporters at the blood-brain barrier.

Miller DS.

Clin Pharmacol Ther. 2015 Apr;97(4):395-403. doi: 10.1002/cpt.64. Epub 2015 Jan 20. Review.

PMID:
25670036
2.

P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery.

Davis TP, Sanchez-Covarubias L, Tome ME.

Adv Pharmacol. 2014;71:25-44. doi: 10.1016/bs.apha.2014.06.009. Epub 2014 Aug 23.

3.

E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers.

Guo M, Sun Y, Zhang Y, Bughio S, Dai X, Ren W, Wang L.

PLoS One. 2014 Jan 31;9(1):e87781. doi: 10.1371/journal.pone.0087781. eCollection 2014.

4.

Sphingolipid signaling reduces basal P-glycoprotein activity in renal proximal tubule.

Miller DS.

J Pharmacol Exp Ther. 2014 Mar;348(3):459-64. doi: 10.1124/jpet.113.210641. Epub 2014 Jan 2.

5.

Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Sanchez-Covarrubias L, Slosky LM, Thompson BJ, Davis TP, Ronaldson PT.

Curr Pharm Des. 2014;20(10):1422-49. Review.

6.

Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers.

Cartwright TA, Campos CR, Cannon RE, Miller DS.

J Cereb Blood Flow Metab. 2013 Mar;33(3):381-8. doi: 10.1038/jcbfm.2012.174. Epub 2012 Nov 21.

7.
8.

Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.

Cannon RE, Peart JC, Hawkins BT, Campos CR, Miller DS.

Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15930-5. Epub 2012 Sep 4.

9.

Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier.

Erickson MA, Hartvigson PE, Morofuji Y, Owen JB, Butterfield DA, Banks WA.

J Neuroinflammation. 2012 Jun 29;9:150. doi: 10.1186/1742-2094-9-150.

10.

P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.

McCaffrey G, Staatz WD, Sanchez-Covarrubias L, Finch JD, Demarco K, Laracuente ML, Ronaldson PT, Davis TP.

J Neurochem. 2012 Sep;122(5):962-75. doi: 10.1111/j.1471-4159.2012.07831.x. Epub 2012 Jul 10.

11.
12.

Different modalities of intercellular membrane exchanges mediate cell-to-cell p-glycoprotein transfers in MCF-7 breast cancer cells.

Pasquier J, Galas L, Boulangé-Lecomte C, Rioult D, Bultelle F, Magal P, Webb G, Le Foll F.

J Biol Chem. 2012 Mar 2;287(10):7374-87. doi: 10.1074/jbc.M111.312157. Epub 2012 Jan 6.

13.

Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.

Agarwal S, Hartz AM, Elmquist WF, Bauer B.

Curr Pharm Des. 2011;17(26):2793-802. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk